Precision Medicine

Top Opportunities for Artificial Intelligence to Improve Cancer Care

by Erin McNemar, MPA

As artificial intelligence (AI) continues to grow in the healthcare field, researchers are findings new ways to utilize its capabilities. In chronic disease management and prevention, especially in cancer research, AI has been critical in...

Population Health Disparities In Cancer Care Promotes Precision Medicine

by Erin McNemar, MPA

Mount Sinai researchers have found genetic differences between 14 tumor types in young adults compared to the same cancers in older adults. To address the population health disparities, researchers...

Triple-Negative Breast Cancer Biomarker A Potential Therapy Target

by Erin McNemar, MPA

Boston University School of Medicine researchers have discovered a metabolic enzyme and pathway in some triple-negative breast cancer (TNBC) patients. According to researchers, the hope is that their...

Predictive Model Determines Antidepressant Medication Response

by Erin McNemar, MPA

Using data from the National Institute of Mental Health, UT Southwestern Medical Center researchers created a predictive model to determine how a patient will respond to antidepressants. According to...

Using Genetic Data For Developing Personalized Cancer Therapies

by Erin McNemar, MPA

Indiana University researchers launched a new study to create personalized therapy for patients with triple-negative breast cancer based on genetic data. According to researchers, risk stratification...

Genetic Signatures Predict Outcomes, Advance Personalized Treatment

by Erin McNemar, MPA

Baylor College of Medicine researchers have discovered a genetic signature that can predict poor patient outcomes in estrogen-receptor positive (ER+) breast cancer, potentially leading to personalized...

Advancing Personalized Treatment For Throat Cancer Patients

by Erin McNemar, MPA

University of California researchers are studying how to advance personalized treatment for patients with HPV-associated oropharyngeal cancer. The research led by Robert Chin, MD, PhD, a radiation...

Machine Learning Predicts Cancer Treatment Response

by Erin McNemar, MPA

The Georgia Institute of Technology and Ovarian Cancer Institute researchers are using machine learning algorithms to predict how patients will respond to cancer-fighting drugs. Advances in machine...

How Metastatic Colorectal Cancer Impacts Population Health

by Erin McNemar, MPA

Although young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups have roughly the same survival rate. That is the main...

Breast Cancer Database to Support Personalized Medicine

by Erin McNemar, MPA

To develop personalized treatment solutions for patients with breast cancer, UC San Diego Health received a $2.1-million gift to launch a comprehensive breast cancer database. Philanthropists Richard...

Predictive Analytics, Genetic Biomarkers Determine Treatment Response

by Erin McNemar, MPA

Using predictive analytics, a genetic biomarker test can determine how men with high-risk prostate cancer will respond to treatment and deliver more personalized medicine. In the study, researchers...

Artificial Intelligence Capable of Predicting COVID-19 Symptoms

by Erin McNemar, MPA

Georgia Institute of Technology and Emory University researchers created a new artificial intelligence-based tool to assist clinicians in predicting which symptoms COVID-19 patients will experience...

Genomics Study Reveals Variants Behind Inherited Retinal Dystrophies

by Erin McNemar, MPA

University of California San Diego and Shiley Eye Institute at UC San Diego Health scientists analyzed how inherited retinal dystrophies (IRDs) impact diverse populations of people. Through the...

Improving Precision Medicine Accessibility Among Admixed Populations

by Erin McNemar, MPA

University of California San Diego School of Medicine researchers have been awarded $11.7 million to launch the Genetic & Social Determinants of Health: Center for Admixture Science and Technology...

New Alzheimer’s Treatment Advances Precision Medicine

by Erin McNemar, MPA

In a study by the National Institute on Aging (NIA), researchers have found that a commonly available oral diuretic pill approved by the United States Food and Drug Administration is a potential...

AI-Based Natural Language Processing Advances Precision Medicine

by Erin McNemar, MPA

To advance their precision medicine research, Washington University School of Medicine has adopted artificial intelligence-based natural language processing tools to assist in sorting their...

Advancing Personalized Medicine For Ventricular Arrhythmias

by Erin McNemar, MPA

To better understand ventricular arrhythmias, Johns Hopkins University researchers are studying the use of whole-heart computational models. Whole-heart computational modeling can lead to personalized...

Genetic Mutations Key to Precision Medicine, Cancer Prevention

by Erin McNemar, MPA

A recent study indicated that genetic mutations in blood cells caused by smoking and aging-related changed could be risk factors for a rare type of blood cancer that impacts immune cells. The findings...

Exploring Artificial Intelligence in Healthcare Around the Globe

by Erin McNemar, MPA

Artificial intelligence (AI) is making a dent in healthcare in the US and around the globe, helping leaders in Europe, South America, and Asia improve outcomes and cut costs, dissolving key pain points...

Predictive Analytics Flags Gynecologic Cancer Relapse in Patients

by Erin McNemar, MPA

Nagourney Cancer Institute researchers in collaboration with the Federal University of Sao Paulo, Brazil, University of California, Irvine, and Todd Cancer Institute discovered metabolic signatures in...